[go: up one dir, main page]

ES2747993T8 - Composiciones farmacéuticas de liberación prolongada de levetiracetam - Google Patents

Composiciones farmacéuticas de liberación prolongada de levetiracetam

Info

Publication number
ES2747993T8
ES2747993T8 ES16728462T ES16728462T ES2747993T8 ES 2747993 T8 ES2747993 T8 ES 2747993T8 ES 16728462 T ES16728462 T ES 16728462T ES 16728462 T ES16728462 T ES 16728462T ES 2747993 T8 ES2747993 T8 ES 2747993T8
Authority
ES
Spain
Prior art keywords
levetiracetam
extended
pharmaceutical compositions
release pharmaceutical
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16728462T
Other languages
English (en)
Other versions
ES2747993T3 (es
Inventor
Michela Gallagher
Sharon Rosenzweig-Lipson
Elsie Melsopp
Jack Lawrence James
Kenneth Garry Payie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agenebio Inc
Original Assignee
Agenebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenebio Inc filed Critical Agenebio Inc
Priority claimed from PCT/US2016/033567 external-priority patent/WO2016191288A1/en
Application granted granted Critical
Publication of ES2747993T3 publication Critical patent/ES2747993T3/es
Publication of ES2747993T8 publication Critical patent/ES2747993T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES16728462T 2015-05-22 2016-05-20 Composiciones farmacéuticas de liberación prolongada de levetiracetam Active ES2747993T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562165812P 2015-05-22 2015-05-22
PCT/US2016/033567 WO2016191288A1 (en) 2015-05-22 2016-05-20 Extended release pharmaceutical compositions of levetiracetam

Publications (2)

Publication Number Publication Date
ES2747993T3 ES2747993T3 (es) 2020-03-12
ES2747993T8 true ES2747993T8 (es) 2021-03-30

Family

ID=61223552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16728462T Active ES2747993T3 (es) 2015-05-22 2016-05-20 Composiciones farmacéuticas de liberación prolongada de levetiracetam

Country Status (4)

Country Link
EP (2) EP3297611B1 (es)
DK (1) DK3297611T3 (es)
ES (1) ES2747993T3 (es)
MA (1) MA50634A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4504176A1 (en) * 2022-04-01 2025-02-12 Agenebio, Inc. Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191803A1 (en) 2002-11-22 2004-09-30 Michela Gallagher Target for therapy of cognitive impairment
EP2682481A3 (en) 2005-08-03 2014-09-17 The Johns-Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
WO2008062446A2 (en) * 2006-09-14 2008-05-29 Alembic Limited An extended release composition of levetiracetam, which exhibits no adverse food effect
ES2865504T3 (es) * 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
KR20120055313A (ko) * 2010-11-23 2012-05-31 주식회사 바이오파마티스 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법
DE102011103270A1 (de) * 2011-05-26 2012-11-29 Stada Arzneimittel Ag Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten
JP6433482B2 (ja) * 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物

Also Published As

Publication number Publication date
ES2747993T3 (es) 2020-03-12
MA50634A (fr) 2021-04-28
EP3590506A1 (en) 2020-01-08
DK3297611T3 (da) 2019-09-02
EP3297611B1 (en) 2019-07-03
EP3297611A1 (en) 2018-03-28

Similar Documents

Publication Publication Date Title
EP3493799A4 (en) CANNABIS
DK3256138T3 (da) Farmaceutiske sammensætninger omfattende meloxicam
DK3529248T3 (da) Farmaceutiske sammensætninger
MA44702A (fr) Compositions de suspension à libération prolongée
EP3513809A4 (en) MEDICAL COMPOSITION
DK3655017T3 (da) Farmaceutisk sammensætning
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
EP3493798A4 (en) CANNABIS
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
EP3364944C0 (en) PHARMACEUTICAL COMPOSITIONS OF IL-2
DK3532029T3 (da) Flydende farmaceutisk sammensætning
EP3334726A4 (en) PINABULIN COMPOSITIONS
IL287520A (en) Levetiracetam extended-release pharmaceutical preparations
EP3310439A4 (en) PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS
DK3583943T3 (da) Farmaceutisk sammensætning
SI3424499T1 (sl) Farmacevtski sestavek za nevropatsko bolečino
JO3456B1 (ar) فيروتيوكسيتين بيروجلوتامات
MA49837A (fr) Compositions pharmaceutiques
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3728220T3 (da) Farmaceutiske forbindelser
SMT202400478T1 (it) Composizione farmaceutica
EP3646863A4 (en) PHARMACEUTICAL COMPOSITION
EP3524250A4 (en) PHARMACEUTICAL COMPOSITION
DK3288933T3 (da) Oxindolforbindelser og farmaceutiske sammensætninger deraf